Compounds > trihexyphenidyl

Page last updated: 2024-08-16

trihexyphenidyl and mecamylamine

trihexyphenidyl has been researched along with mecamylamine in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (33.33)	18.7374
1990's	1 (16.67)	18.2507
2000's	1 (16.67)	29.6817
2010's	2 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bianchi, C; Tomasi, L	1
Vaillant, GE	1
Bymaster, FP; Heath, I; Hendrix, JC; Shannon, HE	1
Hashimura, M; Iha, HA; Iwai, C; Kato, M; Kunisawa, N; Matsubara, N; Nomura, Y; Ogawa, M; Ohno, Y; Onishi, M; Sato, K; Shimizu, S	1

Reviews

1 review(s) available for trihexyphenidyl and mecamylamine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for trihexyphenidyl and mecamylamine

Article	Year
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model. Journal of medicinal chemistry, 2008, Jan-24, Volume: 51, Issue:2 Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase	2008
Central nervous system and autonomic nervous system effects of amantadine and of some standard anti-Parkinson drugs. Pharmacology, 1973, Volume: 10, Issue:4 Topics: Amantadine; Animals; Antiparkinson Agents; Atropine; Autonomic Nervous System; Body Temperature; Carbachol; Central Nervous System; Dihydroxyphenylalanine; Drug Interactions; Gastrointestinal Motility; Male; Mecamylamine; Mice; Mydriatics; Nicotine; Oxotremorine; Phenothiazines; Pupil; Rats; Trihexyphenidyl	1973
A comparison of antagonists of physostigmine-induced suppression of behavior. The Journal of pharmacology and experimental therapeutics, 1967, Volume: 157, Issue:3 Topics: Amphetamine; Animals; Atropine; Behavior, Animal; Chlorpromazine; Columbidae; Diphenhydramine; Haplorhini; Imipramine; Male; Mecamylamine; Muscles; Parasympatholytics; Physostigmine; Scopolamine; Trihexyphenidyl	1967
Comparative behavioral and neurochemical activities of cholinergic antagonists in rats. The Journal of pharmacology and experimental therapeutics, 1993, Volume: 267, Issue:1 Topics: Acetylcholine; Animals; Behavior, Animal; Brain Stem; Cerebral Cortex; Dopamine; Male; Mecamylamine; Memory; Neurotransmitter Agents; Parasympatholytics; Pirenzepine; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Receptors, Muscarinic; Scopolamine; Trihexyphenidyl	1993
Mechanism Underlying Organophosphate Paraoxon-Induced Kinetic Tremor. Neurotoxicity research, 2019, Volume: 35, Issue:3 Topics: Animals; Brain; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Gene Expression; Male; Mecamylamine; Mice; Muscarinic Antagonists; Neurons; Nicotinic Antagonists; Oncogene Proteins v-fos; Paraoxon; Rats; Receptors, Nicotinic; Tremor; Trihexyphenidyl	2019